Krivulka Joseph J 4
4 · NEKTAR THERAPEUTICS · Filed Sep 21, 2017
Insider Transaction Report
Form 4
Krivulka Joseph J
Director
Transactions
- Award
Stock Option
2017-09-19+22,500→ 22,500 totalExercise: $21.75Exp: 2025-09-18→ common stock (22,500 underlying) - Award
Common Stock
2017-09-19+9,000→ 82,000 total
Footnotes (3)
- [F1]This stock award was acquired pursuant to a grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive, upon vesting of the unit, one share of the Issuer's common stock.
- [F2]This restricted stock unit award vests in full, one year following September 19, 2017.
- [F3]This stock option vests in equal monthly installments over the one-year period beginning on September 30, 2017.